Laatste proeven

EudraCT Number: 2006-004882-32 Sponsor Protocol Number: BY1023/NL511 Start Date: 2006-11-20
Sponsor Name: ALTANA Pharma bv
Full Title: Evaluation of clinical endpoints for treatment-induced changes in GERD-related symptoms
Medical condition: gastroesophageal reflux disease (GERD) or Non Erosive Reflux Disease (NERD)
Disease: Version SOC Term Classification Code Term Level
8.1 10017885 Gastrooesophageal reflux disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: View results
EudraCT Number: 2006-002052-15 Sponsor Protocol Number: SPD490-301 Start Date: 2006-11-20
Sponsor Name: Shire
Full Title: An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients with Anaemia Asso...
Medical condition: Anaemia in Chronic Kidney Disease (CKD)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Prematurely Ended) BE (Completed) AT (Prematurely Ended) FR (Completed) DE (Prematurely Ended) IT (Prematurely Ended) LT (Prematurely Ended) LV (Prematurely Ended) HU (Completed)
Trial results: View results
EudraCT Number: 2006-002403-13 Sponsor Protocol Number: Ularitide-1502 Start Date: 2006-11-20
Sponsor Name: PDL BioPharma Inc
Full Title: A Phase 3, Randomized, Double-blinded, Placebo-controlled Study of Ularitide in the Treatment of Subjects with Acute Decompensated Heart Failure
Medical condition: Acute decompensated heart failure
Disease: Version SOC Term Classification Code Term Level
8.1 10000803 Acute heart failure LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Prematurely Ended) LT (Prematurely Ended) AT (Temporarily Halted)
Trial results: (No results available)
EudraCT Number: 2006-000687-89 Sponsor Protocol Number: ICR-CTSU/2008/10018 Start Date: 2006-11-20
Sponsor Name: Institute of Cancer Research
Full Title: A randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder
Medical condition: Non-muscle Invasive Transitional cell Carcinoma of the Bladder
Disease: Version SOC Term Classification Code Term Level
20.0 100000004864 10005004 Bladder cancer NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2006-004749-40 Sponsor Protocol Number: PEDMet 2006-1 Start Date: 2006-11-20
Sponsor Name: Pediatrics
Full Title: Glucose metabolism in patients with neurological/neuromuscular diseases.
Medical condition: Patients with neurological/neuromuscular diseases
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: BE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-004722-82 Sponsor Protocol Number: CSTI571E2204 Start Date: 2006-11-20
Sponsor Name: Novartis Pharma Services AG
Full Title: An exploratory study of the effects of Imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to T...
Medical condition: Seasonal Allergic Rhinitis (sensitivity to Timothy grass pollen)
Disease: Version SOC Term Classification Code Term Level
8.1 10039776 Seasonal allergic rhinitis LLT
Population Age: Adults Gender: Male
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-004516-51 Sponsor Protocol Number: GEN112 Start Date: 2006-11-20
Sponsor Name: Genmab A/S
Full Title: A multicentre open-label, dose-escalation, trial of zanolimumab in combination with CHOP chemotherapy in subjects with CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement
Medical condition: CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement
Disease: Version SOC Term Classification Code Term Level
8.1 10034624 Peripheral T-cell lymphoma unspecified NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Prematurely Ended) DE (Completed) IT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-004735-30 Sponsor Protocol Number: IH 003 Start Date: 2006-11-20
Sponsor Name: Ineos Healthcare Ltd
Full Title: An open label, dose-ranging study to establish the tolerability of Alpharen™ in haemodialysis subjects with hyperphosphataemia.
Medical condition: Hyperphosphataemia in haemodialysis subjects
Disease: Version SOC Term Classification Code Term Level
8.1 10020711 Hyperphosphataemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2006-003409-18 Sponsor Protocol Number: RRC-2/3-2006 Start Date: 2006-11-20
Sponsor Name: Sahlgrenska University Hospital, Östra
Full Title: An Open-label, Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 weeks pegylated interferon alfa-2a 40 kD (PEGASYS®) Combination Therapy with Ribavirin (Copegus®) in Patients with Ch...
Medical condition: chronic hepatitis C (CHC) virus infection genotype 2 or 3 who responded during (i.e. had HCV-RNA
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Ongoing) DK (Completed) FI (Completed)
Trial results: (No results available)
EudraCT Number: 2007-007931-25 Sponsor Protocol Number: 158/06 Start Date: 2006-11-18
Sponsor Name: AZIENDA OSPEDALIERA POLICLINICO DI MODENA
Full Title: Prospective evaluation on the role exerted by the association of ethinylestradiol (0,03 mg) plus clormadinone acetate (2 mg) or ethinylestradiol (0,02 mg) plus desogestrel (0,15 mg) on insulin sens...
Medical condition: Volontari sani
Disease: Version SOC Term Classification Code Term Level
6.1 10038604 SOC
Population Age: Adults Gender: Female
Trial protocol: IT (Completed)
Trial results: (No results available)

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren